or
Bookmark and Share
Treatment of nonacne inflammatory and infectious dermatoses and hair loss
   
Document Number
US Patent 4713394
Issued Date
December 15, 1987
Link
Inventors
Map
Abstract
Dermatoses involving nonacne inflammatory dermatoses, infectious cutaneous diseases, and hair loss resulting from inflammation or hormonal anomalies are treated with dicarboxylic acids containing 7 to 13 carbon atoms, or certain mercapto derivatives or salts thereof.
Tags:
Description:
Amusing 0%
Clever 0%
Complex 0%
Efficient 0%
Historic 0%
Important 0%
Innovative 0%
Interesting 0%
Practical 0%
Simple 0%
Number of Claims:
5
Comments:
no comments yet
Owner
Published
December 15, 1987
Application Number
06/873,859
Filed
June 11, 1986
US Classification
514/574   514/887
Int'l Classification
A61K   8/362   (20060101)   A61K   31/265   (20060101)   A61K   31/19   (20060101)   A61K   31/20   (20060101)   A61K   31/185   (20060101)   A61K   31/21   (20060101)   A61K   8/30   (20060101)   A61Q   5/00   (20060101)   A61Q   19/00   (20060101)   A61Q   7/00   (20060101)  
Attorney/Law Firm
Parent Case
This is a continuation-in-part of application Ser. No. 820,472, filed Jan. 17, 1986, now abandoned.
USPTO Field of Search
514/574  
Related Patents
5547989 - Compositions for treating corns and calluses - Owned by Schering-Plough Healthcare Products, Inc. (Memphis, TN)

Topical compositions in gel form for the treatment of corns and calluses comprising a 7 to 13 carbon dicarboxylic acid and a pharmaceutically acceptable carrier, are described.

4885282 - Treatment of hyperhidrosis, ichthyosis and wrinkling

Skin suffering from emotional hyperhidrosis, ichthyosis with or without keratosis, and intrinsic or photoaging wrinkling is treated with mono- or discarboxylic acids containing 4 to 18 carbon atoms, or certain mercapto derivatives, salts or esters thereof.

5925679 - Topical vehicles containing solubilized and stabilized azelaic acid - Owned by Neutrogena Corporation (Los Angeles, CA)

A completely solubilized alcohol-free topical composition of azelaic acid in a glycol base which is stable at normal temperatures and which is useful as a commercial substitute for dispersed azelaic acid preparations. The composition has a pH of 4.0 or greater thereby substantially reducing irritation.

4868219 - Treatment of skin diseases with aliphatic amines

Noninfectious inflammatory skin diseases in which bacteria or yeasts play a significant adjunctive role are treated with topical formulations of aliphatic amines containing 9 to 18 carbon atoms, and pharmaceutically acceptable salts thereof.

6734210 - Therapeutically improved salts of azelaic acid

Stable salts of azelaic acid with polycations such as chitosan are described. The salts according to the invention are water-soluble, therapeutically more efficacious and are valuable for use as active constituents in pharmaceutical as well as cosmeceutical compositions.

Claims
Description
About| FAQs| Terms & Disclaimer| Link to Us| Contact Us